ersentilide has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beatch, GN; Dickenson, DR; Tang, AS | 1 |
| Adamson, PB; Foreman, RD; Hull, SS; Schwartz, PJ; Vanoli, E | 1 |
2 other study(ies) available for ersentilide and Ventricular Fibrillation
| Article | Year |
|---|---|
Effects of optical enantiomers CK-4000(S) and CK-4001(R) on defibrillation and enhancement of shock-induced extension of action potential duration.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Combined Modality Therapy; Dogs; Electric Countershock; Electrocardiography; Imidazoles; Propanolamines; Random Allocation; Shock; Ventricular Fibrillation | 1995 |
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Cardiac Pacing, Artificial; Dogs; Electric Stimulation; Heart Rate; Imidazoles; Myocardial Infarction; Physical Exertion; Potassium Channel Blockers; Propanolamines; Stellate Ganglion; Ventricular Fibrillation | 1998 |